ангиотензин受体阻断剂可以防止与静脉瘤相关的听力损失
Samuel Early, Alyssa Brown1, Lei Xu2
1Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear and Harvard Medical School, Boston, Massachusetts.
概括
ангиотензин受体阻断剂 (ARBs) 显示出与前庭神经瘤 (VS) 患者的听力保护有显著的关联. 这项现实研究表明,ARBs可能有助于预防VS患者的瘤相关感觉神经听力损失 (SNHL).
科学领域:
- 神经瘤学神经瘤学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 药理学 药理学是指药理学的学科.
背景情况:
- 静脉神经瘤 (VS) 通常会导致感觉神经听力损失 (SNHL).
- 洛萨坦先前在VS的小鼠模型中显示SNHL预防.
- 这项研究调查了ARB对人类VS患者SNHL的影响.
研究的目的:
- 调查血管激素受体阻断剂 (ARB) 使用与前置性神经瘤 (VS) 患者的听力保护之间的联系.
- 评估ARB治疗对人类VS队列中神经感官听力损失 (SNHL) 进展的影响.
主要方法:
- 单边VS患者高血压和顺序听力学 (1994-2023) 的回顾性分析.
- 按抗高血压药物类别进行分层.
- 卡普兰-梅尔分析以评估SNHL进展率.
主要成果:
- 确定了236名患有高血压和听力测量的VS患者.
- 23名患者正在服用ARB;他们显示出更高的基线正常听力和没有渐进性听力损失的可能性.
- 服用其他抗高血压药物的患者表现出听力下降,与VS自然史一致.
结论:
- 这项研究确立了ARB摄入量与VS患者的听力保存之间具有统计学意义的关联.
- 虽然存在混因素,但ARBs似乎是安全的,并且耐受良好.
- 需要进一步的前性临床试验来验证这些发现.
相关概念视频
The Vestibular System
39.3K
The vestibular system is a set of inner ear structures that provide a sense of balance and spatial orientation. This system is comprised of structures within the labyrinth of the inner ear, including the cochlea and two otolith organs—the utricle and saccule. The labyrinth also contains three semicircular canals—superior, posterior, and horizontal—that are oriented on different planes.
39.3K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
381
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
381
Hearing
51.8K
When we hear a sound, our nervous system is detecting sound waves—pressure waves of mechanical energy traveling through a medium. The frequency of the wave is perceived as pitch, while the amplitude is perceived as loudness.
51.8K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
579
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
579
Antihypertensive Drugs: Direct Renin Inhibitors
484
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
484


